Alterations in Immune Function

Alterations in Immune Function

Course Overview

  • Instructor: C Constantin, PhD, RNC

Hypersensitivity Topics

  • Immune Deficiencies

    • Primary Immunodeficiencies

    • Secondary (Acquired) Immunodeficiencies

  • HIV/AIDS

  • Countermeasures to Infection

Hypersensitivity

Specific Objectives

  • Describe and compare the four types of hypersensitivity reactions.

  • Describe how an individual becomes sensitized to an allergen in type I hypersensitivity reactions.

Hypersensitivity Reactions Definition

  • Hypersensitivity: An altered immunologic response to an antigen that leads to disease or damage to the host.

  • Classification methods:

    • Source of Antigen:

    • Allergy

    • Autoimmunity

    • Alloimmunity* (response to antigens from members of the same species)

    • Mechanism Causing Disease:

    • Type I

    • Type II

    • Type III

    • Type IV

Examples of Hypersensitivity and Their Characteristics

  • Type I:

    • Mechanism: IgE-mediated reaction.

    • Rate of Development: Immediate.

    • Principal Effector Cells: Mast cells.

    • Antibody Involvement: No.

    • Disorders: Seasonal allergic rhinitis, latex allergy.

  • Type II:

    • Mechanism: Tissue-specific reaction.

    • Rate of Development: Immediate.

    • Principal Effector Cells: Macrophages in tissues.

    • Antibody Involvement: Frequently.

    • Disorders: Autoimmune thrombocytopenic purpura, Graves' disease.

  • Type III:

    • Mechanism: Immune complex-mediated reaction.

    • Rate of Development: Delayed.

    • Principal Effector Cells: None.

    • Antibody Involvement: Yes.

    • Disorders: Systemic lupus erythematosus.

  • Type IV:

    • Mechanism: Cell-mediated reaction.

    • Rate of Development: Delayed.

    • Principal Effector Cells: Lymphocytes,

      macrophages.

    • Antibody Involvement: No.

    • Disorders: Contact sensitivity to poison ivy and metals.

Sensitization in Hypersensitivity Reactions

  • Sensitization requires exposure to a particular antigen that leads to both primary and secondary immune responses.

  • The sensitization process can be rapid (after just one exposure) or require several exposures.

    • Example: Poison Ivy Reaction, PPD skin test.

Timing of Immune Responses

  • A person is considered sensitized when they possess sufficient antibodies or T cells to cause a measurable reaction upon re-exposure to the antigen.

  • Hypersensitivity reactions may be:

    • Immediate: Minutes to a few hours after exposure.

    • Delayed: Several hours; maximum severity occurs days after re-exposure.

Types of Hypersensitivity Reactions

  • Type I:

    • IgE-mediated reactions leading to anaphylaxis or allergic responses.

    • Examples: Bee stings, drug reactions, asthma, latex allergy.

  • Type II:

    • Tissue-specific antibody-mediated reactions causing destruction of target cells.

    • Conditions: Hemolytic disease of the newborn, autoimmune hemolytic anemia.

  • Type III:

    • Immune complexes cause tissue inflammation and damage.

    • Conditions: Serum sickness, rheumatoid arthritis.

  • Type IV:

    • T-cell mediated responses that are delayed.

    • Conditions: Tuberculosis skin test, poison ivy reactions.

Anaphylaxis
  • Definition: Most rapid and severe immediate hypersensitivity reaction (Type I).

  • Timeframe: Occurs within minutes of re-exposure.

  • Types: Systemic (widespread) and cutaneous (localized).

  • Symptoms of systemic anaphylaxis may include:

    • Itching, erythema, headaches, vomiting, abdominal cramps, diarrhea, and breathing difficulties.

    • Severe cases can involve bronchial smooth muscle contraction, laryngeal edema, and vascular collapse.

Type II Hypersensitivity
  • Description: Antibody-mediated destruction of target cells, usually occurs within 15-30 minutes of exposure.

  • Mechanism: Antibodies bind to specific tissue antigens marking cells for destruction, mediated by complement system and phagocytosis.

  • Symptoms vary based on the affected tissue.

  • Examples of Type II Reactions:

    • ABO transfusion reactions.

    • Hemolytic disease of the newborn.

    • Hyperacute graft rejection.

    • Graves' disease.

    • Myasthenia gravis.

    • Type 1 diabetes mellitus.

Type III Hypersensitivity
  • Mechanism: Antibody-antigen complexes deposit in tissues and activate the complement system causing inflammation and destruction.

  • Etiology: Occurs when immune and phagocytic systems fail to effectively clear these complexes.

  • Conditions: Chronic infection that persists as a source of circulating antigens.

  • Examples:

    • Serum sickness.

    • Immune complex glomerulonephritis.

    • Arthus reaction.

Type IV Hypersensitivity
  • Description: T-cell mediated (no antibody production) resulting in delayed hypersensitivity.

  • Timeframe: Reacts slowly (~24 hours) and may last for 14 days.

  • Mechanism: T-cells react with altered or foreign cells, leading to inflammation.

  • Principal effector cells: Lymphocytes and macrophages.

  • Examples:

    • Tuberculin skin test, contact dermatitis (poison ivy), transplant rejection.

Immune Deficiencies

Types of Immune Deficiencies

  • Primary Immunodeficiencies (PID):

    • Congenital; genetic defects leading to functional deficiencies.

    • Clinical hallmark: Tendency to develop unusual or recurrent severe infections.

  • Secondary Immunodeficiencies:

    • More common; induced by conditions such as cancer, stress, malnutrition, or acquired immunodeficiency (e.g., HIV/AIDS).

Primary Immunodeficiency Disorders

  • Definition: Congenital immune deficiencies caused by genetic defects affecting immunity.

  • Common types:

    • B cell deficiencies.

    • T cell deficiencies.

    • Combined T and B cell deficiencies.

    • Phagocyte deficiencies.

    • Complement deficiencies.

  • Untreated, can lead to frequent and life-threatening infections.

Examples of Primary Immunodeficiencies

  • X-Linked Agammaglobulinemia (Bruton's Disease).

  • Severe Combined Immunodeficiency (SCID): Lack of both B and T lymphocyte function, severe infection susceptibility.

  • Selective IgA Deficiency (fairly common).

Acquired Immunodeficiency Syndrome (AIDS)
  • Definition: Secondary immune deficiency caused by the human immunodeficiency virus (HIV).

  • Characteristics:

    • Blood borne RNA virus present in body fluids.

    • Transmission routes: Blood products, IV drug use, sexual activity, maternal-child.

  • HIV infects and depletes T helper cells (CD4+), increasing susceptibility to infections and malignancies.

  • Statistics:

    • Worldwide incidence (2013): 35.3 million individuals.

    • United States incidence (2012): approximately 49,000 individuals.

Pathogenesis of HIV/AIDS

  • Definition: Retrovirus with RNA genetic material.

  • Mechanism: Uses reverse transcriptase to convert RNA into double-stranded DNA, thus integrating with the host genome.

Human Immunodeficiency Virus (HIV) Structure and Function

  • Structure: gp120 protein binds to CD4 on helper T cells leading to their destruction.

  • Normal CD4+ count ranges from 800800 to 1,0001,000 cells/mm³.

  • HIV typically reverses CD4/CD8 ratio.

Clinical Manifestations of HIV/AIDS

  • Stage Definitions:

    • Serologically negative: no antibodies.

    • Serologically positive but asymptomatic: presence of antibodies but no symptoms.

    • AIDS stage: defined when CD4+ cells fall below 200200 cells/mm³ and benchmark clinical conditions arise.

  • AIDS-defining conditions: include opportunistic infections such as.

    • Pneumocystis jiroveci pneumonia (PCP).

    • Mycobacterium avium complex (MAC).

    • Mycobacterium tuberculosis.

    • Cytomegalovirus (CMV).

    • Kaposi's sarcoma.

    • Candidiasis in respiratory areas.

CD4+ Cell Count and Associated Risks

  • Above 500500 CD4+ cells/mm³: Low infection risk; promote good health practices.

  • 200500200-500 CD4+ cells/mm³: Risk for shingles, thrush, and minor opportunistic infections.

  • 5020050-200 CD4+ cells/mm³: Increased risk for serious opportunistic infections; preventative treatment indicated.

  • Below 5050 CD4+ cells/mm³: High risk for severe opportunistic infections; continued preventative medications recommended.

Treatment of HIV/AIDS
  • Treatment involves taking antiviral medications to slow HIV progression.

  • Antiretroviral Therapy (ART): Combination of three or more drugs offered to optimize treatment outcomes.

  • Components include:

    • Reverse transcriptase inhibitors.

    • Protease inhibitors.

    • Integrase inhibitors.

    • Fusion inhibitors.

    • CCR5 antagonists.

  • Not a cure, but significantly lowers mortality rates.

Worksheet

Immunologic Dysfunction Worksheet

 

1.     Describe what is meant by a hypersensitivity reaction.

hypersensitivity reaction is when the immune system overreacts to something harmless or misidentifies the body’s own cells as harmful, causing tissue damage and disease instead of protection.

🧬 Detailed Pathophysiology Breakdown

What It Means

  • Normally, the immune system protects us by recognizing and destroying harmful invaders (like bacteria, viruses, or toxins).

  • In hypersensitivity, the immune system responds inappropriately — either too strongly or against the wrong target.

  • This exaggerated response leads to collateral damage: inflammation, cell destruction, or dysfunction of normal tissues.

Why It Happens

  1. Sensitization phase

    • On first exposure to an antigen (like pollen, food, or even self-antigens), the immune system “remembers” it.

    • Antibodies (IgE, IgG, IgM) or T cells are primed to react the next time.

  2. Re-exposure phase

    • When the antigen reappears, the immune system launches a stronger, faster attack.

    • Instead of helping, this attack damages normal tissues.

Types (Gell & Coombs Classification)

  • Type I (IgE-mediated): Allergies, asthma, anaphylaxis. Mast cells release histamine → swelling, itching, bronchospasm.

    • ** on slide: basophils also stimulated; Mast cells are connective tissue and basophils are in the blood.

  • Type II (Cytotoxic): Antibodies attack specific cells (e.g., mismatched blood transfusion, Graves disease).

    • She mentioned: remember GRAVES disease, and that Type 2 leads to destruction of cell or altered function of the cell.

  • Type III (Immune complex): Antigen-antibody complexes deposit in tissues → inflammation (e.g., lupus, glomerulonephritis).

  • Type IV (T-cell mediated): Delayed reaction, no antibodies. T cells cause tissue damage (e.g., TB skin test, poison ivy).

Clinical Significance

  • Hypersensitivity explains allergies, autoimmune diseases, and transplant rejection.

  • The key problem is immune misidentification: the body thinks harmless antigens or its own cells are dangerous.

  • Symptoms range from mild (rash, sneezing) to severe (anaphylaxis, organ damage).

Easy Analogy

Think of the immune system as a security guard:

  • Normally, it attacks intruders.

  • In hypersensitivity, the guard panics and attacks friendly visitors or even the building itself, causing damage.

 Key Point for Exams: Hypersensitivity = exaggerated or misdirected immune response → tissue injury and disease.

 

2.     Describe the 4 types of hypersensitivity reactions and give an example of each one.

 

🧬 Four Types of Hypersensitivity Reactions

Type

Mechanism of Immune Reaction (Why it happens)

Example of Reaction

Type I (Immediate / IgE-mediated)

IgE antibodies bind to mast cells → re-exposure to allergen cross-links IgE → mast cells release histamine, leukotrienes, prostaglandins → vasodilation, bronchoconstriction, inflammation.

Allergic asthma, hay fever, bee sting allergy, anaphylaxis

Type II (Cytotoxic / Tissue-specific)

IgG or IgM antibodies bind to antigens on specific cells → complement activation or phagocytosis destroys those cells. Damage is targeted to one tissue.

ABO blood transfusion reaction, Hemolytic disease of the newborn, Graves disease, Myasthenia gravis

Type III (Immune complex-mediated)

Antigen-antibody complexes form in circulation → deposit in tissues → activate complement → attract neutrophils → inflammation and tissue damage. Not tissue-specific, depends on where complexes lodge.

Systemic lupus erythematosus (SLE), post-strep glomerulonephritis, serum sickness, Arthus reaction

Type IV (Delayed / T-cell mediated)

Sensitized T lymphocytes (CD4+ helper and CD8+ cytotoxic) react directly to antigen → release cytokines → recruit macrophages → tissue damage. No antibodies involved. Reaction peaks 48–72 hrs.

Tuberculin skin test (PPD), poison ivy contact dermatitis, transplant rejection

Easy Memory Hook

  • Type I = Immediate (IgE, Allergies)

  • Type II = “It’s on the cell” (antibody attacks tissue)

  • Type III = “Immune Complexes clog” (deposit in tissues)

  • Type IV = “Delayed T-cell” (cell-mediated, no antibodies)

 Exam Key Point: Types I–III are antibody-mediated, Type IV is T-cell mediated.

 

 

3.     What is a clinical sign that an individual has a primary immunodeficiency? Which cells are affected when a person has a primary immunodeficiency?

🧬 Primary Immunodeficiency

Clinical Sign

·       The hallmark sign is recurrent, unusual, or severe infections that don’t respond normally to treatment.

·       These infections often begin in early childhood (before age 2) and may involve unusual organisms or repeated infections in the same sites (ears, sinuses, lungs, skin).

·       Example: a child with repeated pneumonia, ear infections, or thrush despite antibiotics.

Why? Because the immune system is missing or defective from birth (genetic defect), the body cannot mount normal defenses → infections keep coming back.

Cells Affected

Primary immunodeficiencies can involve any major immune cell type, depending on the genetic defect:

·       B cells (humoral immunity) → ↓ antibodies → recurrent bacterial infections (e.g., X-linked agammaglobulinemia).

·       T cells (cell-mediated immunity) → ↓ cytotoxic/helper function → viral, fungal, opportunistic infections.

·       Combined T & B cell defects → severe combined immunodeficiency (SCID, “boy-in-the-bubble”).

·       Phagocytes → impaired ability to engulf/kill pathogens → chronic bacterial infections.

·       Complement proteins → defective opsonization/lysis → recurrent Neisseria infections.

Why? Each immune cell type has a specialized role. If one is missing, the “defense team” is incomplete → pathogens slip through.

Key Exam Point

·       Clinical sign: recurrent, severe, or unusual infections (especially in young children).

·       Cells affected: can be B cells, T cells, both, phagocytes, or complement proteins, depending on the genetic defect.

 

 

4.     What can cause secondary immunodeficiency?

🧬 Secondary (Acquired) Immunodeficiency

Definition

·       Unlike primary immunodeficiency (genetic, present from birth), secondary immunodeficiency develops later in life due to external factors that weaken the immune system.

·       It is much more common than primary forms.

Causes (and the “Why”)

1.     Infections

o   Example: HIV/AIDS → virus destroys CD4+ T helper cells.

o   Why? Loss of T cells cripples both humoral and cell-mediated immunity.

2.     Cancer

o   Leukemia, lymphoma, or bone marrow cancers.

o   Why? Malignant cells crowd out normal immune cells → reduced production/function.

3.     Medications/Drugs

o   Chemotherapy, radiation, immunosuppressants, corticosteroids.

o   Why? These treatments kill rapidly dividing cells, including immune cells, or suppress immune activity.

4.     Poor Nutrition/Malnutrition

o   Protein-calorie malnutrition, vitamin/mineral deficiencies (zinc, iron).

o   Why? Nutrients are required for lymphocyte development and antibody production.

5.     Stress/Neuroendocrine factors

o   Chronic stress → ↑ cortisol.

o   Why? Cortisol suppresses lymphocyte activity and inflammation.

6.     Normal Physiologic Changes

o   Aging → gradual decline in immune function (“immunosenescence”).

o   Why? Bone marrow and thymus activity decrease, fewer naïve T cells produced.

Key Exam Point

·       Secondary immunodeficiency = acquired later in life due to infection, disease, drugs, nutrition, stress, or aging.

·       Why? These factors either destroy immune cells, suppress their function, or prevent their production.

 

 

5.     Describe how the human immunodeficiency virus (HIV) is transmitted. How does HIV cause disease?  

 

🧬 Transmission of HIV

HIV is a blood-borne RNA virus found in body fluids. It is transmitted when infected fluids come into direct contact with mucous membranes or the bloodstream.

Main routes:

·       Sexual contact (heterosexual or homosexual) → virus enters through genital/rectal mucosa.

·       Blood exposure → transfusions (rare now), needle sharing, IV drug use.

·       Mother-to-child → during pregnancy, birth, or breastfeeding.

·       Healthcare exposure → accidental needle sticks.

Why? HIV is fragile outside the body but survives in blood and certain fluids. Transmission requires direct fluid-to-blood/mucosa contact.

🧬 How HIV Causes Disease

1.     Entry into cells

o   HIV has a surface protein (gp120) that binds specifically to CD4 receptors on T helper cells.

o   It also needs co-receptors (CCR5 or CXCR4) to enter.

o   On slide she mentioned on EXAM: Structure – gp120 protein binds to the CD4 molecule found primarily on surface of helper Tcells

1.     Destroys CD4 + Th cells.

2.     Replication

o   HIV is a retrovirus → it carries RNA and uses reverse transcriptase to convert RNA → DNA.

o   Viral DNA integrates into host genome → host cell becomes a “virus factory.”

3.     Destruction of CD4+ T cells

o   Infected T helper cells are destroyed directly or undergo apoptosis.

o   Over time, CD4 count drops (normal ~800–1000 cells/mm³ → AIDS <200 cells/mm³).

4.     Immune system collapse

o   Without T helper cells, both cell-mediated immunity (T cells) and humoral immunity (B cells/antibodies)fail.

o   Body becomes vulnerable to opportunistic infections (PCP pneumonia, CMV, TB, candidiasis) and cancers (Kaposi’s sarcoma, lymphoma).

Why? HIV targets the “commanders” of the immune system (CD4+ T cells). When commanders are gone, the rest of the immune army cannot coordinate defense → infections and malignancies take over.

Key Exam Points

·       Transmission: blood, sexual contact, mother-to-child, needle exposure.

·       Pathophysiology: HIV binds CD4 → enters cells → reverse transcriptase → integrates DNA → destroys T helper cells → immune collapse.

·       Result: Opportunistic infections and cancers define AIDS.

 

 

6.     What is the criteria for assigning a diagnosis of AIDS? List some of the “AIDS-defining conditions”.

🧬 Criteria for AIDS Diagnosis

A person is diagnosed with AIDS (Acquired Immunodeficiency Syndrome) when:

1.     CD4+ T helper cell count < 200 cells/mm³ (normal is ~800–1000).

o   Why? HIV destroys CD4+ cells, which are the “commanders” of the immune system. Below 200, the immune system can no longer coordinate defense.

2.     Presence of AIDS-defining conditions (opportunistic infections or cancers).

o   Why? These infections/cancers only occur when the immune system is severely weakened.

3.     Positive HIV test (antibodies or viral RNA detected).

🧬 AIDS-Defining Conditions

These are illnesses that signal the immune system is critically compromised:

·       Opportunistic infections

o   Pneumocystis jiroveci pneumonia (PCP)

o   Mycobacterium avium complex (MAC)

o   Mycobacterium tuberculosis (TB)

o   Cytomegalovirus (CMV) infection

o   Candidiasis (esophagus, bronchi, trachea, lungs)

·       Cancers

o   Kaposi’s sarcoma (vascular tumor linked to HHV-8)

o   Non-Hodgkin lymphoma

o   Invasive cervical cancer

·       Other severe conditions

o   Wasting syndrome (unexplained weight loss >10% with diarrhea/weakness/fever)

o   Recurrent bacterial infections

Key Exam Point

·       Diagnosis of AIDS = HIV infection + CD4 <200 + AIDS-defining condition.

·       Why? At this stage, the immune system is so damaged that infections and cancers normally controlled by immunity can now take hold.
On slide in Red: CD4 (T helper) cells need to be <200 cells/mm3 AND they have to have various clinical conditions and lab results.

 

 

7.     Drugs used to treat HIV infection target different aspects of how a virus infects a cell and replicates. Name the type of drugs used in Antiretroviral therapy (ART).

 

🧬 Antiretroviral Therapy (ART) Drug Classes

Drug Class

Mechanism (Why it helps)

Example Drugs

Reverse Transcriptase Inhibitors (RTIs)

HIV is a retrovirus → it must convert its RNA into DNA using reverse transcriptase. RTIs block this enzyme, stopping viral DNA formation.

Zidovudine (AZT), Lamivudine, Tenofovir

Protease Inhibitors (PIs)

HIV makes long protein chains that must be cut by protease into functional viral proteins. PIs block protease → virus particles remain immature and noninfectious.

Ritonavir, Indinavir

Integrase Inhibitors

HIV DNA must be inserted into host cell DNA by integrase. These drugs block integrase → viral DNA cannot integrate → infection stalls.

Raltegravir, Dolutegravir

Fusion Inhibitors

HIV must fuse with the host cell membrane to enter. Fusion inhibitors block this step → virus cannot get inside.

Enfuvirtide

CCR5 Antagonists (Entry Inhibitors)

HIV uses co-receptor CCR5 to enter CD4+ cells. These drugs block CCR5 → virus cannot attach/enter.

Maraviroc

Key Exam Point

·       ART = combination therapy (usually 3+ drugs from different classes).

·       Why? HIV mutates quickly. Using multiple drug classes prevents resistance and attacks the virus at multiple stages: entry → reverse transcription → integration → protein processing.

 Summary for your study guide: ART drugs include reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, fusion inhibitors, and CCR5 antagonists. Each targets a different step in HIV’s life cycle to stop replication.